bbic-bridge-logo

B-BIC News and Events:
What's Happening

NIH Centers for Accelerated Innovations Program: principles, practices, successes and challenges

By B-BIC | September 25, 2017

Commercializing innovations in academic environments is notoriously challenging. Here, we describe the progress of the NIH Centers for Accelerated Innovations program — initiated in 2013 to address these challenges — which we believe could help set a new standard for the early-stage commercialization of biomedical innovations in academic environments. Read More On Nature.com.

Read More

FAST PITCH FOR FUNDING: FAQ

By B-BIC | September 12, 2017

Q:  Do I need to have slides?  A:  Pitches only need to address the suggested elements.  Use of reference materials or other visual elements is welcome if they help convey the product concept and can be shared using your laptop screen.  AV equipment will not be available. Q:  How formal will the pitches be? A:…

Read More

FAST PITCH FOR FUNDING: What we are looking for when awarding B-BIC partnerships

By B-BIC | September 12, 2017

Potential for commercialization. Technology that addresses an unmet clinical need. Heart, Lung, Blood or Sleep indications. Preliminary data indicating promise of commercialization. Differentiation from competitors. IP filings, with institutions as the assignee. FAST PITCH FOR FUNDING is November 3 at 10:00am at Harvard Medical School.  This event will provide you with the opportunity to pitch a…

Read More

FAST PITCH FOR FUNDING: Quick Tips for a successful pitch

By B-BIC | September 12, 2017

Keep pitch short and focused on the technology and its commercial application. Limit the discussion of preliminary results, and focus on the most relevant results with conclusions – not data. Present the science within the context of the business strategy.   This FAST PITCH FOR FUNDING is November 3, 2017 at 10:00am at Harvard Medical School.  This event provides…

Read More

Specialist Series: Reimbursement

By B-BIC | September 11, 2017

If reimbursement is so important … why do so many companies address it so half-heartedly and so late? Edward E. Berger, Ph.D. Everyone knows how important reimbursement analysis and planning is to the success of innovative medical technology and life science products.  Ask any venture capitalist, private equity investor, strategic marketing analyst, or C-level executive;…

Read More

NEW AWARD: CONGRATULATIONS DR. LEO TSAI!

By B-BIC | September 5, 2017

RECIPIENT: Dr. Leo Tsai TITLE: A Novel Coaxial Deflectable Microcatheter for Rapid Navigation of Tortuous Vessels TYPE OF AWARD: DRIVE INSTITUTION: Beth Israel Deaconess Medical Center TECHNOLOGY TYPE: Therapeutic Device DESCRIPTION: Microcatheters are used to access small vessels throughout the body to treat a wide variety of pathology, from traumatic hemorrhage to tumors. Selection of…

Read More

Bringing the Immunity-to-Change™ process to the scientific community

By B-BIC | August 3, 2017

Community member post by Erica Lawlor and Cheryl Vaughan How can scientists whose careers were formed in an incentive system that cultivates competitive and territorial behaviors be helped to meet the expectations of collaborative research frameworks? A team-based approach that transcends disciplinary boundaries may be a tall order for scientists who “grew up” in a…

Read More

Specialist Series: Your Elevator Pitch: Don’t leave home without it!

By B-BIC | July 17, 2017

Written by Melissa Marshall Have you ever walked away from a conversation about your work with an important individual and thought, “Darn. I wish I would have explained that better or said it this way instead…”? Or maybe you had an unexpected interaction with someone who asked about your work and you just started rambling…

Read More

NEW AWARD: CONGRATULATIONS DR. BEN MATTHEWS

By B-BIC | June 9, 2017

RECIPIENT:  Dr. Ben Matthews TITLE: PR1P, an inhaled novel short peptide for emphysema TYPE OF AWARD:  PILOT INSTITUTION: Boston Children’s Hospital DESCRIPTION:  Emphysema is a chronic progressive pulmonary disease characterized by destruction of alveoli leading to impaired lung function that threatens human health worldwide. Disease progression is due in part to dysregulation of the survival factor Vascular Endothelial Growth Factor (VEGF). …

Read More

Specialist Series: Patents

By B-BIC | June 9, 2017

What is a U.S. patent? A patent is a property right. The property right granted is an exclusionary right, i.e., the right to exclude others from making, using, offering for sale, or selling an invention. In the US, generally this exclusionary right lasts for 20 years from the date of the initial filing of an…

Read More